Cargando…
Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia
Introduction. Glioblastoma multiforme (GBM) is the most malignant primary brain tumor in adults. Recent whole-genome studies revealed novel GBM prognostic biomarkers such as mutations in metabolic enzyme IDH—isocitrate dehydrogenases (IDH1 and IDH2). The distinctive mutation IDH1 R132H was uncovered...
Autores principales: | Polivka, J., Rohan, V., Pesta, M., Repik, T., Pitule, P., Topolcan, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910481/ https://www.ncbi.nlm.nih.gov/pubmed/24511544 http://dx.doi.org/10.1155/2014/735659 |
Ejemplares similares
-
Stroke care in West Bohemia – personalised medicine approach
por: Polivka, Jiri, et al.
Publicado: (2014) -
IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme
por: Polívka, Jiří, et al.
Publicado: (2018) -
Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016) -
Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
por: Cai, Xiaomin, et al.
Publicado: (2022) -
Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas
por: Hsieh, Kevin Li-Chun, et al.
Publicado: (2017)